NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Evident Vascular

Evident Vascular

Private
San Jose, CaliforniaHealthcare & Life Scienceshttps://evidentvascular.com/

Last Round

Series B

Mar 25, 2025

Total Funding Raised

$35M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Evident Vascular is a medical technology company that develops an AI-powered intravascular ultrasound (IVUS) platform designed to enhance image interpretation and streamline workflows for peripheral and coronary vascular interventions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

intravascular ultrasoundIVUSAI-powered medical imagingmedical devicevascular imagingAI-assisted surgeryinterventional cardiologymedtechvascular interventiondigital healthmedical AIclinical workflowdiagnostic imaging

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Evident Vascular Comps

Public and private peers based on sector, stage, and business model.

Evident Vascular comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Evident Vascular Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMar 25, 2025
Series AOct 17, 2023

Key People

Founding team and executive leadership

Patrick Phillips

Chief Technology Officer Co-Founder

Founding Team

Howard Rosen

Chief Executive Officer Co-Founder

Founding Team

Paul Chan

Chief Financial Officer

Executive Team

Evident Vascular Investors

Notable investors and investment history

Evident Vascular investors
InvestorRounds
Vensana CapitalSeries B, Series A
ShangBay CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 27, 2026

    Grew 15% QoQ, from 33 to 38 employees.

  • Jan 7, 2025

    Scott R. Ward appointed to the Board of Directors.

Evident Vascular Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Evident Vascular Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Evident Vascular's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Jose, California
Employee Range38
Year Founded2021
Last FundingMar 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.